Alprazolam (Xanax)

566  relevant articles (99 outcomes, 133 trials/studies) found for this Drug

Xanax; Kalma; Apo-Alpraz; Ralozam; Tafil; Trankimazin; Esparon; Alphapharm Brand of Alprazolam; Alprox; Apotex Brand of Alprazolam; Arzneimittelwerk Dresden Brand of Alprazolam; Cassadan; D-65MT; Kenral Brand of Alprazolam; Novo-Alprazol; Novopharm Brand of Alprazolam; Nu-Alpraz; Nu-Pharm Brand of Alprazolam; Orion Brand of Alprazolam; Pharmacia Brand of Alprazolam; Temmler Brand of Alprazolam; U-31,889; Upjohn Brand of Alprazolam; Alprazolam Alphapharm Brand; Alprazolam Apotex Brand; Alprazolam Kenral Brand; Alprazolam Novopharm Brand; Alprazolam Nu-Pharm Brand; Alprazolam Orion Brand; Alprazolam Pharmacia Brand; Alprazolam Temmler Brand; Alprazolam Upjohn Brand; Apo Alpraz; ApoAlpraz; D65MT; Novo Alprazol; NovoAlprazol; Nu Alpraz; Nu Pharm Brand of Alprazolam; NuAlpraz; U31,889; Alprazolan; 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-

Relationship Network

Drug Context: Research Results

Experts

1.	Starcevic, Vladan: 2 articles (01/2008 - 10/2006)
2.	Uhlenhuth, E H: 2 articles (01/2008 - 10/2006)
3.	Qualls, Clifford: 2 articles (01/2008 - 10/2006)
4.	Barnhill, Jamie: 2 articles (01/2008 - 10/2006)
5.	Antal, Edward J: 2 articles (01/2008 - 10/2006)
6.	Javaid, Javaid I: 2 articles (01/2008 - 10/2006)
7.	Matuzas, William: 2 articles (01/2008 - 10/2006)
8.	Rickels, Karl: 2 articles (09/2005 - 07/2004)
9.	Greenblatt, D J: 2 articles (06/2000 - 01/2000)
10.	Shader, R I: 2 articles (06/2000 - 01/2000)

Related Diseases

1.	Panic Disorder (Panic Attack) 08/01/1993 - "CONCLUSIONS: These results suggest that sustained-release alprazolam is highly effective in the acute treatment of panic disorder at doses comparable to those in the originally marketed compressed tablet of alprazolam" 12/01/1984 - "Blockade of panic attacks with TCAs, MAOIs and alprazolam has dramatically improved our ability to treat these disorders, with 60 to 95 per cent of patients reporting marked alleviation of symptoms" 06/01/1986 - "Alprazolam treatment led to a complete remission of panic attacks in 85% of the patients; panics ceased within an average of 6 days, at a mean dose of 2.2 mg/day" 10/01/1993 - "Studies of plasma alprazolam concentration versus clinical response during short-term treatment of panic disorder indicate that therapeutic response at steady-state plasma levels of 20 to 40 ng/mL is significantly greater than at levels less than 20 ng/mL. Substantial additional benefit from plasma levels greater than 40 ng/mL is not consistently demonstrated" 04/01/1992 - "A recently reported multinational, 8-week double-blind, placebo-controlled study assessing the efficacy of alprazolam versus placebo in the treatment of panic disorder indicated significant differences favoring alprazolam" Order ALL the reference details at left...
2.	Agoraphobia 01/01/1999 - "A previous study with agoraphobia/panic patients found that the BZ alprazolam impaired memory during an 8-week treatment and residual impairments were still manifest several weeks after drug withdrawal (Curran et al. 1994)" 01/01/1999 - "Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients." 10/01/1991 - "House calls and alprazolam for agoraphobia." 01/01/1988 - "Fading of therapeutic effects of alprazolam in agoraphobia" 01/01/1987 - "A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented" Order ALL the reference details at left...
3.	Anxiety Disorders (Anxiety Disorder) 06/01/2000 - "In study 2, 11 patients with anxiety disorders receiving alprazolam (0.8-2.4 mg/day) ingested grapefruit juice (600 ml/day) for 7 days" 01/01/1998 - "Fifty-four patients with an anxiety disorder, stabilized on alprazolam, entered the study" 08/01/1995 - "RESEARCH DESIGN AND METHODS--Fifty-eight patients with poor glycemic control, 16 (27.6%) of whom had a symptomatic generalized anxiety disorder, were entered into a randomized, double-blind, placebo-controlled, 8-week trial using alprazolam (up to 2 mg/day) as the active agent" 01/01/1992 - "In a double-blind, placebo-controlled study, the efficacy and safety of alprazolam was investigated in childhood and adolescent anxiety disorders" 09/01/1995 - "1. Alprazolam, a triazolobenzodiazepine, is extensively prescribed for the treatment of anxiety disorders, which predominantly affect women of child-bearing age" Order ALL the reference details at left...
4.	Phobic Disorders (Phobia) 09/01/1992 - "Alprazolam was significantly effective for panic and anxiety variables in PDA, while exposure was significantly effective for phobia variables" 06/01/1993 - "By the end of treatment, though gains on alprazolam were largely as in previous studies, on phobias and disability they were half those with exposure" 05/01/1988 - "Fourteen patients with DSM-III social phobia were treated with alprazolam in an open study" 01/01/2007 - "No advantage was found to combining alprazolam with systematic desensitization for dental injection phobia." 01/01/2007 - "Combining alprazolam with systematic desensitization therapy for dental injection phobia." Order ALL the reference details at left...
5.	Vomiting 08/01/1993 - "The mean number of vomiting episodes was significantly smaller in the alprazolam group (1.31 +/- 2.61 vs 2.89 +/- 4.59 times) (p < .01)" 04/01/1991 - "The mean frequency of vomiting in the alprazolam group was 1.18 times, which is significantly smaller than 2.25 times in the untreated group (p less than 0.05)" 08/01/1993 - "The mean duration of nausea and vomiting was significantly shorter in the alprazolam group (p < .001 and p < .01)" 04/01/1991 - "The mean duration of vomiting and nausea was significantly shorter in the alprazolam group (p less than 0.01, p less than 0.05)" 04/01/1991 - "Of 22 cases evaluated, 8 in the alprazolam group and 1 in the untreated group were free from nausea and vomiting (p less than 0.01)" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Benzodiazepines
2.	Imipramine (Janimine)
3.	Clonazepam (Rivotril)
4.	Propranolol (Inderal)
5.	Diazepam (Valium)
6.	Phenelzine (Nardil)
7.	Alprazolam (Xanax)
8.	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
9.	Lorazepam (Ativan)
10.	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Adjuvant Chemotherapy
3.	Aftercare (After-Treatment)
4.	Emergency Treatment
5.	Deep Brain Stimulation